These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 30640663)
41. Insight into the dynamic of gadolinium based contrast agent (GBCA) hypersensitivity: Acquisition, persistence and disappearance. Boehm I; Hungerbühler M; Heverhagen JT Magn Reson Imaging; 2018 Jun; 49():1-3. PubMed ID: 29247752 [TBL] [Abstract][Full Text] [Related]
42. Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes. Kane GC; Stanson AW; Kalnicka D; Rosenthal DW; Lee CU; Textor SC; Garovic VD Nephrol Dial Transplant; 2008 Apr; 23(4):1233-40. PubMed ID: 18256017 [TBL] [Abstract][Full Text] [Related]
43. Hypersensitivity reactions and contrast medium injection: are they always related? Böhm I; Alfke H; Klose KJ Eur J Radiol; 2011 Nov; 80(2):368-72. PubMed ID: 21251786 [TBL] [Abstract][Full Text] [Related]
44. Hypersensitivity to contrast media and dyes. Brockow K; Sánchez-Borges M Immunol Allergy Clin North Am; 2014 Aug; 34(3):547-64, viii. PubMed ID: 25017677 [TBL] [Abstract][Full Text] [Related]
45. Gadopentetate dimeglumine as a contrast agent in peripheral angioplasty. A case report. Murphy JM; O'Hare NJ; Smiddy P; Molloy MP Acta Radiol; 1998 Sep; 39(5):576-8. PubMed ID: 9755712 [TBL] [Abstract][Full Text] [Related]
46. Serum Neutrophil Gelatinase-Associated Lipocalin and Urinary Kidney Injury Molecule-1 as Potential Biomarkers of Subclinical Nephrotoxicity After Gadolinium-Based and Iodinated-Based Contrast Media Exposure in Pediatric Patients with Normal Kidney Function. Spasojević-Dimitrijeva B; Kotur-Stevuljević J; Đukić M; Paripović D; Miloševski-Lomić G; Spasojević-Kalimanovska V; Pavićević P; Mitrović J; Kostić M Med Sci Monit; 2017 Sep; 23():4299-4305. PubMed ID: 28874655 [TBL] [Abstract][Full Text] [Related]
47. Gadolinium use in spine pain management procedures for patients with contrast allergies: results in 527 procedures. Safriel Y; Ang R; Ali M Cardiovasc Intervent Radiol; 2008; 31(2):325-31. PubMed ID: 17939000 [TBL] [Abstract][Full Text] [Related]
48. Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests. Berti A; Della-Torre E; Yacoub M; Tombetti E; Canti V; Sabbadini MG; Colombo G Eur Ann Allergy Clin Immunol; 2016 Jul; 48(4):137-44. PubMed ID: 27425169 [TBL] [Abstract][Full Text] [Related]
49. The use of gadolinium for arterial interventions. Sambol EB; Van der Meer JG; Graham A; Goldstein LJ; Karwowski JK; Dayal R; Derubertis B; Kent KC Ann Vasc Surg; 2011 Apr; 25(3):366-76. PubMed ID: 21288688 [TBL] [Abstract][Full Text] [Related]
50. Acute adverse reactions to radiographic iodinated and gadolinium-based contrast media: incidence, risk factors and premedication: from published evidence to a practical approach. Tonolini M; Bianco R Clin Ter; 2011; 162(6):591-4. PubMed ID: 22262334 [TBL] [Abstract][Full Text] [Related]
51. [Recommendations of the European Society of Urogenital Radiology on the use of contrast media and the opportunity to use paramagnetic contrast in patients allergic to iodinated contrast media treated with endourology]. Fariña LA; Alonso MV Actas Urol Esp; 2002; 26(10):820. PubMed ID: 12645382 [No Abstract] [Full Text] [Related]
53. Prevention of generalized reactions to contrast media: a consensus report and guidelines. Morcos SK; Thomsen HS; Webb JA; Eur Radiol; 2001; 11(9):1720-8. PubMed ID: 11511894 [TBL] [Abstract][Full Text] [Related]
54. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study. Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321 [TBL] [Abstract][Full Text] [Related]
55. Gadolinium-containing contrast media for radiographic examinations: a position paper. Thomsen HS; Almèn T; Morcos SK; Eur Radiol; 2002 Oct; 12(10):2600-5. PubMed ID: 12271402 [TBL] [Abstract][Full Text] [Related]
56. Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients. Abujudeh HH; Kaewlai R; Kagan A; Chibnik LB; Nazarian RM; High WA; Kay J Radiology; 2009 Oct; 253(1):81-9. PubMed ID: 19709997 [TBL] [Abstract][Full Text] [Related]
57. The Evidence for and Against Corticosteroid Prophylaxis in At-Risk Patients. Davenport MS; Cohan RH Radiol Clin North Am; 2017 Mar; 55(2):413-421. PubMed ID: 28126223 [TBL] [Abstract][Full Text] [Related]
58. Gadolinium use for interventional pain procedures: where we are and where we are heading. Durbhakula S; Cohen SP Reg Anesth Pain Med; 2019 Jan; 44(1):4-6. PubMed ID: 30640646 [TBL] [Abstract][Full Text] [Related]
59. Immediate Mild Reactions to CT with Iodinated Contrast Media: Strategy of Contrast Media Readministration without Corticosteroids. Park SJ; Kang DY; Sohn KH; Yoon SH; Lee W; Choi YH; Cho SH; Kang HR Radiology; 2018 Sep; 288(3):710-716. PubMed ID: 29786483 [TBL] [Abstract][Full Text] [Related]
60. Metrizamide myelography in patients with iodine allergy or previous adverse reactions to iodinated contrast media. Tallroth K Spine (Phila Pa 1976); 1987; 12(6):574-6. PubMed ID: 3660084 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]